Davis Selected Advisers Sells 1,267,195 Shares of Humana Inc. $HUM

Davis Selected Advisers lowered its position in Humana Inc. (NYSE:HUM) by 76.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 385,539 shares of the insurance provider’s stock after selling 1,267,195 shares during the period. Davis Selected Advisers owned about 0.32% of Humana worth $100,306,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Elevation Point Wealth Partners LLC bought a new position in Humana in the second quarter valued at about $32,000. Mather Group LLC. bought a new stake in shares of Humana during the 3rd quarter valued at about $34,000. AlphaCore Capital LLC bought a new stake in shares of Humana during the 2nd quarter valued at about $39,000. Private Wealth Management Group LLC increased its position in shares of Humana by 47.5% during the 3rd quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock valued at $39,000 after purchasing an additional 48 shares during the last quarter. Finally, Larson Financial Group LLC increased its position in shares of Humana by 114.1% during the 3rd quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock valued at $40,000 after purchasing an additional 81 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on HUM shares. Evercore dropped their price objective on shares of Humana from $260.00 to $180.00 in a report on Thursday, February 12th. Raymond James Financial decreased their price target on shares of Humana from $340.00 to $230.00 and set an “outperform” rating on the stock in a research report on Friday, February 13th. Jefferies Financial Group dropped their price target on shares of Humana from $310.00 to $235.00 and set a “buy” rating on the stock in a research note on Thursday, February 12th. UBS Group reissued a “neutral” rating on shares of Humana in a research report on Wednesday, February 25th. Finally, Cantor Fitzgerald reduced their price objective on Humana from $290.00 to $201.00 and set a “neutral” rating for the company in a research note on Thursday, February 12th. Seven research analysts have rated the stock with a Buy rating, sixteen have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, Humana presently has an average rating of “Hold” and a consensus target price of $225.48.

Humana Trading Down 0.1%

Humana stock opened at $170.54 on Thursday. Humana Inc. has a 12-month low of $163.60 and a 12-month high of $315.35. The firm has a market capitalization of $20.47 billion, a price-to-earnings ratio of 17.37, a P/E/G ratio of 1.83 and a beta of 0.44. The firm has a 50 day moving average of $206.51 and a 200 day moving average of $245.16. The company has a current ratio of 2.00, a quick ratio of 2.00 and a debt-to-equity ratio of 0.70.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share for the quarter, beating the consensus estimate of ($4.01) by $0.05. The business had revenue of $32.64 billion for the quarter, compared to the consensus estimate of $32.08 billion. Humana had a net margin of 0.92% and a return on equity of 11.43%. The company’s revenue for the quarter was up 11.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($2.16) earnings per share. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. As a group, research analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, March 27th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 2.1%. Humana’s payout ratio is 36.05%.

Insiders Place Their Bets

In other Humana news, insider Sanjay K. Shetty purchased 810 shares of the business’s stock in a transaction on Monday, February 23rd. The stock was acquired at an average price of $185.21 per share, for a total transaction of $150,020.10. Following the purchase, the insider owned 11,657 shares of the company’s stock, valued at approximately $2,158,992.97. This represents a 7.47% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.20% of the company’s stock.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.